ArisGlobal, a life sciences software provider, has acquired SPORIFY, a data harmonization technology solution used by five of the world’s top 20 largest pharmaceutical companies. The financial details of the acquisition were not disclosed. This acquisition is part of ArisGlobal’s strategy to develop an open architecture that fosters connectivity within the life sciences ecosystem. By incorporating SPORIFY, ArisGlobal aims to enhance patient safety, expedite therapy development, and enable swift responses to supply chain disruptions.
What You Should Know:
- ArisGlobal, a provider of life sciences software acquires SPORIFY, the trusted substances, products, organizations and referentials (SPOR) data harmonization technology solution for five of the world’s top 20 largest pharmaceutical companies. Financial details of the acquisition were not disclosed.
- With its second acquisition in the last 90 days, ArisGlobal is prioritizing the development of an open architecture that enables an interconnected life sciences ecosystem.
- The addition of SPORIFY will improve patient safety with interoperable systems and data standards, bring therapies to market faster, and allow stakeholders to react to supply chain disruptions quickly.
Source: HitConsultant
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.